India's first AI-led Incidental Pulmonary Nodule Detection Clinic opens at Thangam Cancer Centre, Tamil Nadu. Part of Project ...

Clinical stage diagnostics company AccuStem Sciences has acquired the licence for the microRNA Signature Classifier (MSC) ...

Leadoptik has entered a research partnership with Stanford Medicine, focusing on real-time optical imaging usage in lung ...

Qure.ai, a global leader in artificial intelligence (AI) for healthcare, today announced the launch of India’s first AI-led ...

In another case study, CyPath® Lung helped physicians identify and treat a recurrence of breast cancer in a high-risk patient.

AccuStem pursuing strategic commercialization plan intending to launch the MSC test in the US in 2026LONDON and PHOENIX, Ariz., March 18, 2025 ...

NEW YORK – Cancer diagnostics firm AccuStem Sciences announced on Tuesday that it has acquired the license for the proprietary MicroRNA Signature Classifier (MSC) test for lung cancer screening from ...

It invested in a robotic, noninvasive technology for biopsies of hard-to-reach lesions in the lungs and to remove suspected ...

The firm is preparing for a trial to show the efficacy of its CyPath Lung test and support a submission to the US Food and Drug Administration for marketing clearance.

Good Samaritan announced in a recent press release the addition of the Ion Endoluminal System, a state-of-the-art ...

AccuStem pursuing strategic commercialization plan intending to launch the MSC test in the US in 2026 LONDON and PHOENIX, Ariz., March 18, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB ...